Furthermore, our analyses revealed that increased intensity of STXBP1, EMILIN2, and CDH2 was associated with poor prognosis in LCNEC and SCLC (Fig. 5F and Fig. S12C and D). This evidence concerns the gene EMILIN2 and large cell neuroendocrine carcinoma.